GenMark Dx's mission is to become the market leader in providing high value, simple to perform, clinically relevant multiplex molecular tests to aid in the diagnosis of disease and the selection and dosing of therapies.
For investor information, please contact IR@genmarkdx.com.
May 3, 2016
GenMark Reports First Quarter 2016 Results
May 3, 2016 at 4:30 PM ET
GenMark Diagnostics First Quarter Earnings Conference Call